Close Menu

technology development

The deal between the firms grants Quest the rights to use Genomic Vision's technology to develop tests for breast and ovarian cancer, among other diseases.

Systems Biology in Action


The Ottawa Institute of Systems Biology is still getting its momentum going, but it's already seen promising work in proteomics and spawned collaborations among its members.

The company, which until recently has focused almost exclusively "on cell-based work," expects that the delivery technology will facilitate its in vivo work and enable RNAi-based therapeutics.

NHGRI will award around $120 million in grants over this year and next year under the stimulus act.

Personalized medicine

Short Reads: Mar 27, 2009


News in brief

Included in the $787 billion stimulus package is additional funding for capital instrument purchases and a new $200 million program to tackle new gaps in knowledge, technologies, and research that could provide immediate rewards with the additional money.

Al Luderer, Kevin Krenitsky

William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.

NHLBI in late January put out an RFP for the program, which calls for researchers to develop proteomics technologies and apply them to solve clinical puzzles. It is set to begin early next year, shortly after its current two major proteomics initiatives expire.


A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.